Bone sarcomas

Acta Oncologica

Volumn 35, Issue SUPPL. 7, 1996, Pages 123-124

  Alvegård, Thor ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE TUMOR; CHONDROSARCOMA; CLINICAL TRIAL; EWING SARCOMA; HUMAN; META ANALYSIS; MULTIMODALITY CANCER THERAPY; OSTEOSARCOMA; SARCOMA;

BONE NEOPLASMS; CHONDROSARCOMA; COMBINED MODALITY THERAPY; HUMANS; OSTEOSARCOMA; SARCOMA; SARCOMA, EWING'S;

EID: 0030325044     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841869609101672     Document Type: Review

References (28)

1. Friedman M, Carter S, The therapy of osteogenic sarcoma: Current status and thoughts for the future. J Surg Oncol 1972; 4: 482-510. (Ll)
2. Rosen G, Caparros B, Huvos A, et al. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982; 49: 1221-30. (R1/57) (Pubitemid 12187826)
3. Rosen G, Nirenberg A. Neoadjuvant chemotherapy for osteogenic sarcoma: A five-year follow-up (T-10) and preliminary report of new studies (T-12). Prog Clin Biol Res 1985; 201: 39-51. (R1/76)
4. Bacci G, Gherlinzoni F, Picci P, et al. Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: A randomized study. Eur J Cancer Clin Oncol 1986; 22: 1337-45. (C2/106) (Pubitemid 17183460)
5. Goorin A, Perez-Atayde A, Gebhardt M, et al. Weekly highdose methotrexate and doxorubicin for osteosarcoma: The Dana-Farber Cancer Institute/The Children's Hospital study III. J Clin Oncol 1987; 5: 1178-84. (R2/46) (Pubitemid 18045302)
6. Winkler K, Beron G, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma: Results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 1988; 6: 329-37. (C1/141) (Pubitemid 18065939)
7. Benjamin R, Raymond A, Carrasco C, et al. Primary chemotherapy of osteosarcoma of the extremities with systemic adriamycin and intra-arterial cisplatinum. Proc Am Assoc Clin Oncol 1989; 8: 322. (02/50)
8. Solheim O, Alvegård T, Elomaa I. Adjuvant chemotherapy for osteosarcoma. A preliminary report from the Scandinavian Sarcoma Group, Acta Oncol 1989; 28 (Suppl 2): 53-7. (C1/83)
9. Pratt C, Champion J, Fleming I, et al. Adjuvant chemotherapy for osteosarcoma of the extremity. Long-term results of two consecutive prospective protocol studies. Cancer 1990; 65: 439-45. (R1/76)
10. Saeter G, Alvegird T. Elomaa I, et al. Treatment of osteosarcoma of the extremities with the T-10 protocol. with emphasis on the effects of preoperative chemotherapy with single agent high-dose methotrexate. A Scandinavian Sarcoma Group study. J Clin Oncol 1991: 9: 1766-75. (C1/97)
11. Solheim OP, Saeter G. Elomaa I, Alvegård T. The treatment of osteosarcoma: Present trends. The Scandinavian Sarcoma Group experience. Ann Oncol 1992; 3 (Suppl2): S7-I I. (L1)
12. Gaitan-Yanguas M. A study of the response of osteogenic sarcoma and adjacent normal tissues to irradiation. Int J Radiat Oncol Biol Phys 1981; 7: 593-5. (O2) (Pubitemid 11072539)
13. Rab G, lvins J, Childs D, et al. Elective whole lung irradiation in the treatment of osteogenic sarcoma. Cancer 1976; 38: 939-42. (C1/53)
14. Newton K, Barrett A. Prophylactic lung irradiation in the treatment of osteogenic sarcoma. Clin Radiol 1978; 29: 493-5. (R3/14)
15. Weichselbaum R, Cassady J, Jaffe N, et al. Preliminary results of aggressive multimodality therapy for metastatic osteosarcoma. Cancer 1977; 40: 78-83. (P1/10) (Pubitemid 8160506)
16. Marcove R, Lewing M. Prolonged survival in osteogenic sarcoma with multiple pulmonary metastasis. J Bone Joint Surg 1973; 55A: 1516-20. (R1/24)
17. Fromm M, Littman P, Raney R, et al. Late effects after treatment of twenty children with soft tissue sarcomas of the head and neck. Experience at a single institution with review of the literature. Cancer 1986; 57: 2070-6. (R2/20) (Pubitemid 16113788)
18. Tefft M, Chabora B. Rosen G. Radiation in bone sarcomas: A re-evaluation in the era of intensive systemic chemotherapy. Cancer 1977; 39: 806-16. (L1) (Pubitemid 8060269)
19. Rosen G, Caparros B, Nirenberg A, et al. Ewing's sarcoma: Ten-year experience with adjuvant chemotherapy. Cancer 1981; 47: 2204-13. (R1/67) (Pubitemid 11098590)
20. Perez C, Teft M, Nesbit M, et al. Radiation therapy in the multimodal management of Ewing's sarcoma: Report of the InterGroup Ewing's Sarcoma Study. Natl Cancer Inst Monogr 1981; 56: 263-71. (L1) (Pubitemid 12193870)
21. Bacci G, Toni A, Avella M, et al. Long term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer 1989; 63: 1477-86. (R1/144) (Pubitemid 19093268)
22. Dunst J, Sauer R, Burgers J, et al. Radiotherapy in Ewing's sarcoma: Current results of the German Society of Pediatric Oncology studies CESS 81 and CESS 86. Klin Pediatr 1988; 200: 261-6. (Ll)
23. Alvegård T, Solheim O. akerman M, Berg N. Ewing's sarcoma. A preliminary report from the Scandinavian Sarcoma Group, Acta Oncol 1989; (Suppl 2): 59-64. (R1/48)
24. Horowitz M, Neff J, Kun L. Ewing's sarcoma. Radiotherapy versus surgery for local control. Ped Clin North Am 1991; 38: 365-80. (L1)
25. Kinsella T, Mitchell M, McPherson S, et al. In vitro radiation studies on Ewing's sarcoma cell lines and human bone marrow. Application to the clinical use of total body irradiation (TBI). Int J Radiat Oncol Biol Phys 1984; 10: 1005-11. (O1) (Pubitemid 14096086)
26. Brown A, Fixsen J, Plowman P, Local control of Ewing's sarcoma: An analysis of 67 patients. Br j Radiol 1987; 60: 261-8. (R1/67) (Pubitemid 17029104)
27. Austin-Seymour M, Munzenrider J, Goitein M, et al. Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg 1989; 70: 13-74 (O2)
28. Jürgens H, Exner U, Gadner H, et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. Cancer 1988; 61: 23-32. (C1 1/215)